Amy Newlands

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial

Saifudin Khalid, Robert Murdoch, Amy Newlands et al. · Journal of Allergy and Clinical Immunology · 2014 · 178 citations · Full text

Asthma, Allergy, Immunology +4

Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial

Jinping Zheng, Teresita De Guia, Jie Wang‐Jairaj et al. · Current Medical Research and Opinion · 2015 · 51 citations · Full text

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

Chris Kalberg, Dianne M. O’Dell, Dmitry Galkin et al. · Drugs in R&D · 2016 · 41 citations · Full text

Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study

J Zheng, Nanshan Zhong, Amy Newlands et al. · International Journal of COPD · 2015 · 35 citations · Full text

Inhibition of capsaicin‐driven nasal hyper‐reactivity by <scp>SB</scp>‐705498, a <scp>TRPV</scp>1 antagonist

Carlijn Holland, Cornelis M. van Drunen, Jane Denyer et al. · British Journal of Clinical Pharmacology · 2013 · 31 citations · Full text